339 results on '"McRae-Clark, Aimee L."'
Search Results
2. Sex and Gender Differences in Simultaneous Alcohol and Cannabis Use: a Narrative Review
3. Oxytocin moderates fMRI connectivity and response to implicit threat processing in cocaine use disorder
4. Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis
5. A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder
6. Restructuring reward: A pilot study to enhance natural reward response in adults with cannabis use disorder
7. Developmental trajectories of alcohol and cannabis concurrent use in a nationally representative sample of United States youths
8. Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access
9. Sex and drug differences in stress, craving and cortisol response to the trier social stress task
10. Distress tolerance and reactivity to negative affective cues in naturalistic environments of cannabis-using emerging adults
11. A preliminary investigation of the role of intraindividual sleep variability in substance use treatment outcomes
12. Correction to: Consideration of sex and gender differences in addiction medication response
13. Consideration of sex and gender differences in addiction medication response
14. Tobacco–cannabis co-use among cancer patients and survivors: findings from 2 US cancer centers.
15. A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem
16. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
17. Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women
18. Varenicline as a Treatment for Cannabis Use Disorder: A Placebo-Controlled Pilot Trial
19. Exploration Into Patterns of Cannabis Use Across Pregnancy and Postpartum.
20. Neurotransmitter and Neuropeptide Targets for Cannabis Use Disorder Treatment
21. Cannabis Use Disorder as a Developmental Disorder
22. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
23. Comparison of three magnetic resonance imaging measures of brain iron in healthy and cocaine use disorder participants
24. Exploring the Utility of a Functional Magnetic Resonance Imaging (fMRI) Cannabis Cue-Reactivity Paradigm in Treatment Seeking Adults with Cannabis Use Disorder
25. Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
26. Methods to reduce the incidence of false negative trial results in substance use treatment research
27. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder
28. Comparison of three magnetic resonance imaging measures of brain iron in healthy and cocaine use disorder participants.
29. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence
30. Novel Collaborations Across Training Programs to Support Mentoring in Sex Differences Research
31. Mechanisms of Career Enhancement at Specialized Centers of Research Excellence (SCORE) on Sex Differences
32. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials
33. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial
34. Sex differences in the relationship between cannabis use motives and cannabis craving in daily life in emerging adults.
35. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
36. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States
37. Cannabis Use Disorder as a Developmental Disorder
38. Neurotransmitter and Neuropeptide Targets for Cannabis Use Disorder Treatment
39. Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders
40. Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women
41. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial
42. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence
43. Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence
44. Modeling Cannabis Use Disorder Treatment Progression: Evidence for Unconventional Explanations of Functional Improvements
45. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
46. Therapeutic Benefit of Smoked Cannabis in Randomized Placebo‐Controlled Studies
47. Methylphenidate Transdermal System in Adults with Past Stimulant Misuse: An Open-Label Trial
48. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence
49. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse
50. Association of elevated cytokines with childhood adversity in a sample of healthy adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.